货币 / MLYS
MLYS: Mineralys Therapeutics Inc
15.05
USD
0.99
(7.04%)
今日MLYS汇率已更改7.04%。当日,交易品种以低点13.97和高点15.13进行交易。
关注Mineralys Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MLYS新闻
- Zacks Mineralys Therapeutics, Inc. (MLYS) Upgraded to Buy: Here's Why
- Zacks Does Mineralys Therapeutics, Inc. (MLYS) Have the Potential to Rally 154.21% as Wall Street Analysts Expect?
- Investing Mineralys Therapeutics CEO Congleton sells $230k in shares
- Investing Mineralys Therapeutics CFO Adam Levy sells $155k in stock
- TipRanks 3 Best Stocks to Buy Now, 7/15/2025, According to Top Analysts - TipRanks.com
- Investing Jefferies maintains Hold rating on Mineralys stock amid AstraZeneca data
- Investing Mineralys reports positive phase 3 results for hypertension drug
- Investing Mineralys stock holds Buy rating at H.C. Wainwright after CKD trial
- Benzinga Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps - Mineralys Therapeutics (NASDAQ:MLYS)
- Investing Mineralys Therapeutics stock jumps after positive kidney disease trial data
- Investing Mineralys reports positive phase 2 data for lorundrostat in CKD
- Seeking Alpha PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
- Benzinga This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Core Natural Resources (NYSE:CNR), Coinbase Global (NASDAQ:COIN)
- Investing Jefferies initiates Mineralys Therapeutics stock with hold rating
- Seeking Alpha Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
- Seeking Alpha Mineralys Therapeutics: Merits A Small 'Speculative' Holding (NASDAQ:MLYS)
- Investing Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension
- Investing Mineralys to present lorundrostat trial data at ESH 2025
- Investing Mineralys at BofA Securities 2025: Lorundrostat’s Hypertension Promise
- TipRanks 3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts - TipRanks.com
- TipRanks 3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts - TipRanks.com
- Investing Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual
- Benzinga Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Lazard (NYSE:LAZ), Amylyx Pharmaceuticals (NASDAQ:AMLX)
- Seeking Alpha Mineralys: Prospects Just Got Better With Successful Pivotal Data Readouts (NASDAQ:MLYS)
日范围
13.97
15.13
年范围
8.24
18.99
- 前一天收盘价
- 13.88
- 开盘价
- 14.06
- 卖价
- 15.05
- 买价
- 15.35
- 最低价
- 13.97
- 最高价
- 15.13
- 交易量
- 662
- 日变化
- 7.04%
- 月变化
- 11.65%
- 6个月变化
- 46.12%
- 年变化
- 20.50%
30 七月, 星期三
12:15
USD
- 实际值
- 104 K
- 预测值
- 57 K
- 前值
- -33 K
12:30
USD
- 实际值
- 3.0%
- 预测值
- 0.4%
- 前值
- -0.5%
12:30
USD
- 实际值
- 2.0%
- 预测值
- 3.6%
- 前值
- 3.8%
12:30
USD
- 实际值
- 2.5%
- 预测值
- 3.3%
- 前值
- 3.5%
12:30
USD
- 实际值
- 2.1%
- 预测值
- 3.1%
- 前值
- 3.7%
12:30
USD
- 实际值
- 1.4%
- 预测值
- 0.8%
- 前值
- 0.5%
12:30
USD
- 实际值
- 6.3%
- 预测值
- -1.5%
- 前值
- -3.1%
14:00
USD
- 实际值
- -0.8%
- 预测值
- 1.6%
- 前值
- 1.8%
14:00
USD
- 实际值
- -2.8%
- 预测值
- 9.6%
- 前值
- 1.1%
14:00
USD
- 实际值
- 72.0
- 预测值
- 前值
- 72.6
14:30
USD
- 实际值
- 7.698 M
- 预测值
- 0.914 M
- 前值
- -3.169 M
14:30
USD
- 实际值
- 0.690 M
- 预测值
- 0.114 M
- 前值
- 0.455 M
14:30
USD
- 实际值
- 1.317 M
- 预测值
- 0.738 M
- 前值
- -0.740 M
14:30
USD
- 实际值
- 0.130 M
- 预测值
- -0.004 M
- 前值
- 0.095 M
14:30
USD
- 实际值
- 3.635 M
- 预测值
- -0.111 M
- 前值
- 2.931 M
14:30
USD
- 实际值
- 0.676 M
- 预测值
- 0.915 M
- 前值
- 0.282 M
14:30
USD
- 实际值
- 0.739 M
- 预测值
- 0.608 M
- 前值
- 0.003 M
14:30
USD
- 实际值
- -2.724 M
- 预测值
- 0.879 M
- 前值
- -1.738 M
14:30
USD
- 实际值
- -0.025 M
- 预测值
- 前值
- 0.087 M
14:30
USD
- 实际值
- -0.1%
- 预测值
- 前值
- 1.6%
18:00
USD
- 实际值
- 预测值
- 前值
18:00
USD
- 实际值
- 4.50%
- 预测值
- 前值
- 4.50%
18:30
USD
- 实际值
- 预测值
- 前值